Abacus backs LonguVue Capital's acquisition of Summit Clinical Research

Abacus made an equity co-investment in SCR.

21 November 2022•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.